This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
420An increase in serum creatinine during intensive blood pressure therapy is not associated with adverse cardiorenal outcomes in patients with type 2 diabetes. (28th August 2018)
Record Type:
Journal Article
Title:
420An increase in serum creatinine during intensive blood pressure therapy is not associated with adverse cardiorenal outcomes in patients with type 2 diabetes. (28th August 2018)
Main Title:
420An increase in serum creatinine during intensive blood pressure therapy is not associated with adverse cardiorenal outcomes in patients with type 2 diabetes